Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
Zoya Kurago, Gang Guo, Huidong Shi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Showing 18 citing articles:

Simultaneous blockade of the CD73/EGFR axis inhibits tumor growth
Keivan Ardeshiri, Hadi Hassannia, Ghasem Ghalamfarsa, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 1
Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 19-39
Closed Access | Times Cited: 7
CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathway
Karla Cano Hernandez, Akansha M. Shah, Víctor López, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 4
Open Access | Times Cited: 5
Oncolytic Virus Therapy in a New Era of Immunotherapy, Enhanced by Combination with Existing Anticancer Therapies: Turn up the Heat!
Emily Charlotte Fretwell, Annwyne Houldsworth
Journal of Cancer (2025) Vol. 16, Iss. 6, pp. 1782-1793
Open Access
Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant bisphosphonate use
Nataliia Petruk, Steven L. Wood, Walter M. Gregory, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E
Junqian Zhang, Xiaobo Zhang, R. Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities
Shambhavi Borde, Sandro Matosevic
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 832-848
Closed Access | Times Cited: 12
Targeting the adenosine signaling pathway in macrophages for cancer immunotherapy
Yang Han, Zongliang Zhang, Kai Zhao, et al.
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110774-110774
Closed Access | Times Cited: 3
Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response
Reem Youssef, Rohan Maniar, Jaffar M. Khan, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9753-9767
Open Access | Times Cited: 7
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
Andrea Timpanaro, Caroline Piccand, Dzhangar Dzhumashev, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 6
PET imaging of colon cancer CD73 expression using cysteine site-specific 89Zr-labeled anti-CD73 antibody
Kyung‐Ho Jung, Mina Kim, Hye Jin Jung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Posttranslational protein modifications as gatekeepers of cancer immunogenicity
Emanuela Marchese, Shadmehr Demehri
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 1
CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 Axis
Lin Liang, Chunxue Yue, Wentao Li, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e37958-e37958
Open Access | Times Cited: 1
Optimising CAR T therapy for the treatment of solid tumors
Norhan Mobark, Caroline Hull, John Maher
Expert Review of Anticancer Therapy (2024), pp. 1-17
Open Access
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
Tingting Zhong, Lingzhi Zhang, Zhaoliang Huang, et al.
iScience (2024) Vol. 28, Iss. 3, pp. 111722-111722
Open Access
Comprehensive genome editing confers ‘off-the-shelf’ CAR-T cells superior efficacy against solid tumors
Ryan Murray, Nuria Roxana Romero Navarrete, Kashvi Desai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Decoding Cancer’s Metabolic Manipulation: Exploring the Influence of the Tumor Microenvironment on Immune Cell Metabolism and Antitumoral Response
Reem Youssef, Rohan Maniar, Jaffar M. Khan, et al.
(2023)
Open Access | Times Cited: 1
CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
Andrea Timpanaro, Caroline Piccand, Dzhangar Dzhumashev, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top